{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:18:56Z","timestamp":1786972736501,"version":"build-2736575974"},"reference-count":26,"publisher":"Bentham Science Publishers Ltd.","issue":"7","funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences","doi-asserted-by":"publisher","award":["1402-3-102-67676"],"award-info":[{"award-number":["1402-3-102-67676"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPPS"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>Secreted Frizzled-Related Protein 2 (SFRP2) is considered to be the\nmost potent modulator of the Wnt signaling. This pathway is involved in the pathogenesis of Polycystic\nOvary Syndrome (PCOS). This research aimed to compare the levels of SFRP2 in PCOS\n[infertile and Recurrent Pregnancy Loss (RPL) patients] with the control group and determine the\ncorrelation of SFRP2 with inflammation and insulin resistance.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>This case-control study was conducted on 108 POCS patients (53 infertile patients and\n55 women with RPL) and 54 healthy controls. The levels of biochemical factors along with SFRP2,\nadiponectin, Luteinizing Hormone (LH), Follicle-Stimulating Hormone (FSH), free testosterone,\nand insulin, high-sensitivity C-Reactive Protein (hs-CRP) were measured following the\nmanufacturer's instructions.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Both infertile and RPL groups presented notably higher levels of SFRP2 (49.32 \u00b1 17.72\nng\/ml and 55.89 \u00b1 17.36 ng\/ml, respectively) compared to the control group (30.21 \u00b1 10.12 ng\/ml,\nP&lt;0.001 for both groups). In PCOS patients, a positive correlation was observed between SFRP2\nand body mass index (BMI) (r = 0.42, P &lt; 0.001), insulin (r = 0.19, P = 0.04), fasting blood glucose\n(FBG) (r = 0.24, P = 0.01), Homeostatic Model Assessment for Insulin Resistance (HOMA-\nIR) (r = 0.21, P = 0.03), triglyceride (r = 0.25, P = 0.009), and hs-CRP (r = 0.21, P = 0.02).\nFurthermore, SFRP2 increased the risk of RPL (OR [95% CI] = 1.15 [1.10 -1.20], P &lt; 0.001) and\ninfertility (OR [95% CI] = 1.12 [1.07 -1.17], P &lt; 0.001) in comparison with the controls.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Our findings suggested that SFRP2 may have a potential involvement in the development\nof PCOS and might be a promising target for diagnosis, but additional research is required to\nconfirm this.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0113892037339007250120100322","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T05:58:46Z","timestamp":1739426326000},"page":"585-592","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Circulating SFRP2 in Iranian Polycystic Ovarian Syndrome Patients with Infertility and Recurrent Pregnancy Loss and its Correlation with Insulin Resistance and Inflammation"],"prefix":"10.2174","volume":"26","author":[{"given":"Ali Abdul Kareem","family":"Jawad","sequence":"first","affiliation":[{"name":"Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Tehran University of Medical Sciences,\nTehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Nabatchian","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Tehran University of Medical Sciences,\nTehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nariman","family":"Moradi","sequence":"additional","affiliation":[{"name":"Liver and Digestive Research Center, Research Institute for Health Development, Kurdistan University\nof Medical Sciences, Sanandaj, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Choobineh","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Tehran University of Medical Sciences,\nTehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Fadaei","sequence":"additional","affiliation":[{"name":"Sleep Disorders Research Center, Kermanshah University of Medical Sciences,\nKermanshah, Iran"},{"name":"Department of Pharmacology, Vanderbilt University, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Afrisham","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Tehran University of Medical Sciences,\nTehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s40618-019-01108-4","volume":"43","author":"Bicer M.","year":"2020","unstructured":"Bicer M.; Alarslan P.; Guler A.; Demir I.; Aslanipour B.; Calan M.; Elevated circulating levels of secreted frizzled-related protein 4 in relation to insulin resistance and androgens in women with polycystic ovary syndrome. J Endocrinol Invest  2020,43(3),305-313","journal-title":"J Endocrinol Invest"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"e27943","DOI":"10.7759\/cureus.27943","volume":"14","author":"Jabeen A.","year":"2022","unstructured":"Jabeen A.; Yamini V.; Rahman Amberina A.; Dinesh Eshwar M.; Vadakedath S.; Begum G.S.; Kandi V.; Polycystic ovarian syndrome: Prevalence, predisposing factors, and awareness among adolescent and young girls of South India. Cureus  2022,14(8),e27943","journal-title":"Cureus"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.fertnstert.2010.11.036","volume":"95","author":"Escobar-Morreale H.F.","year":"2011","unstructured":"Escobar-Morreale H.F.; Luque-Ram\u00edrez M.; Gonz\u00e1lez F.; Circulating inflammatory markers in polycystic ovary syndrome. A systematic review and metaanalysis. Fertil Steril  2011,95(3),1048-1058","journal-title":"Fertil Steril"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s40618-015-0392-6","volume":"39","author":"\u0130nal H.A.","year":"2016","unstructured":"\u0130nal H.A.; Yilmaz N.; Gorkem U.; Oruc A.S.; Timur H.; The impact of follicular fluid adiponectin and ghrelin levels based on BMI on IVF outcomes in PCOS. J Endocrinol Invest  2016,39(4),431-437","journal-title":"J Endocrinol Invest"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/B978-0-12-813209-8.00027-3","author":"Barber T.","year":"2019","unstructured":"Barber T.; Franks S.;  Genetic and Environmental Factors in the Etiology of Polycystic Ovary Syndrome The Ovary  2019,437-459","journal-title":"Genetic and Environmental Factors in the Etiology of Polycystic Ovary Syndrome The Ovary"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/9240569","volume":"2022","author":"Xu Y.","year":"2022","unstructured":"Xu Y.; Qiao J.; Association of insulin resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): A review of literature. J Healthc Eng  2022,2022(1),1-13","journal-title":"J Healthc Eng"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e0263658","DOI":"10.1371\/journal.pone.0263658","volume":"17","author":"Vatannejad A.","year":"2022","unstructured":"Vatannejad A.; Fadaei R.; Salimi F.; Fouani F.Z.; Habibi B.; Shapourizadeh S.; Eivazi S.; Eivazi S.; Sadeghi A.; Moradi N.; Plasma Complement C1q\/tumor necrosis factor-related protein 15 concentration is associated with polycystic ovary syndrome. PLoS One  2022,17(6),e0263658","journal-title":"PLoS One"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4103\/2230-8210.107830","volume":"17","author":"Kamalanathan S.","year":"2013","unstructured":"Kamalanathan S.; Sahoo J.; Sathyapalan T.; Pregnancy in polycystic ovary syndrome. Indian J Endocrinol Metab  2013,17(1),37-43","journal-title":"Indian J Endocrinol Metab"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1183060","DOI":"10.3389\/fendo.2023.1183060","volume":"14","author":"Wartena R.","year":"2023","unstructured":"Wartena R.; Matjila M.; Polycystic ovary syndrome and recurrent pregnancy loss, a review of literature. Front Endocrinol  2023,14,1183060","journal-title":"Front Endocrinol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"e2695","DOI":"10.1210\/clinem\/dgaa285","volume":"105","author":"Cena H.","year":"2020","unstructured":"Cena H.; Chiovato L.; Nappi R.E.; Obesity, polycystic ovary syndrome, and infertility: A new avenue for GLP-1 receptor agonists. J Clin Endocrinol Metab  2020,105(8),e2695-e2709","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"5535","DOI":"10.2174\/1381612822666160726103133","volume":"22","author":"Dimitriadis G.","year":"2016","unstructured":"Dimitriadis G.; Kyrou I.; Randeva H.; Polycystic ovary syndrome as a proinflammatory state: The role of adipokines. Curr Pharm Des  2016,22(36),5535-5546","journal-title":"Curr Pharm Des"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1007\/s11033-018-4360-z","volume":"45","author":"Inal Z.O.","year":"2018","unstructured":"Inal Z.O.; Inal H.A.; Erdem S.; The effect of serum and follicular fluid secreted frizzle-related protein-5 on in vitro fertilization outcomes in patients with polycystic ovary syndrome. Mol Biol Rep  2018,45(6),2037-2044","journal-title":"Mol Biol Rep"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S1001-7844(12)60032-7","volume":"23","author":"Wang Y.","year":"2012","unstructured":"Wang Y.; Zhu W.; Evaluation of adiponectin, resistin, IL-6, TNF-\u03b1 in obese and non-obese women with polycystic ovary syndrome. Reprod Contracept  2012,23(4),237-244","journal-title":"Reprod Contracept"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/molehr\/gar010","volume":"17","author":"Maman E.","year":"2011","unstructured":"Maman E.; Yung Y.; Cohen B.; Konopnicki S.; Dal Canto M.; Fadini R.; Kanety H.; Kedem A.; Dor J.; Hourvitz A.; Expression and regulation of sFRP family members in human granulosa cells. Mol Hum Reprod  2011,17(7),399-404","journal-title":"Mol Hum Reprod"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1093\/labmed\/lmae030","volume":"55","author":"Alhilfi A.S.N.","year":"2024","unstructured":"Alhilfi A.S.N.; Afrisham R.; Sefidan A.M.; Fadaei R.; Moradi N.; Saed L.; Einollahi N.; A positive correlation of serum SFRP1 levels with the risk of developing type 2 diabetes mellitus: A case- control study. Lab Med  2024,55(6),739-744","journal-title":"Lab Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13048-021-00847-4","volume":"14","author":"Zhang Y.","year":"2021","unstructured":"Zhang Y.; Ran Y.; Kong L.; Geng L.; Huang H.; Zhang H.; Hu J.; Qi H.; Chen Y.; Decreased SFRP5 correlated with excessive metabolic inflammation in polycystic ovary syndrome could be reversed by metformin: Implication of its role in dysregulated metabolism. J Ovarian Res  2021,14(1),97","journal-title":"J Ovarian Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"e0163777","DOI":"10.1371\/journal.pone.0163777","volume":"11","author":"Crowley R.K.","year":"2016","unstructured":"Crowley R.K.; O\u2019Reilly M.W.; Bujalska I.J.; Hassan-Smith Z.K.; Hazlehurst J.M.; Foucault D.R.; Stewart P.M.; Tomlinson J.W.; SFRP2 is associated with increased adiposity and VEGF expression. PLoS One  2016,11(9),e0163777","journal-title":"PLoS One"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"100060","DOI":"10.1016\/j.eurox.2019.100060","volume":"3","author":"Ajmal N.","year":"2019","unstructured":"Ajmal N.; Khan S.Z.; Shaikh R.; Polycystic ovary syndrome (PCOS) and genetic predisposition: A review article. Eur J Obstet Gynecol Reprod Biol  2019,3,100060","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"723205","DOI":"10.3389\/fcvm.2021.723205","volume":"8","author":"Cao M.","year":"2021","unstructured":"Cao M.; Wang H.; Li W.; Jiang X.; Wang X.; Guo W.; Gao P.; Zou Y.; Inverse associations between circulating secreted frizzled related protein 2 (sFRP2) and cardiometabolic risk factors. Front Cardiovasc Med  2021,8,723205","journal-title":"Front Cardiovasc Med"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.37080\/nmj.148","volume":"5","author":"Kumar Shrewastwa M.","year":"2023","unstructured":"Kumar Shrewastwa M.; Acharya V.; Kumar Mahat A.; Association of secreted frizzled-related protein 4 with obesity and type II diabetes. Nepal Med J  2023,5(2),50-56","journal-title":"Nepal Med J"},{"key":"ref=21","first-page":"629","author":"Beernink R.H.","year":"2022","unstructured":"Beernink R.H.; Schuitemaker J.H.;  Secreted Frizzled-Related Proteins 4 and 5: What They Are and Can They Be Used as a Biomarker in Gestational Diabetes Mellitus Biomarkers in Diabetes  2022,629-648","journal-title":"Secreted Frizzled-Related Proteins 4 and 5: What They Are and Can They Be Used as a Biomarker in Gestational Diabetes Mellitus Biomarkers in Diabetes"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"103282","DOI":"10.1016\/j.resp.2019.103282","volume":"270","author":"Zhou M.","year":"2019","unstructured":"Zhou M.; Jiao L.; Liu Y.; sFRP2 promotes airway inflammation and Th17\/Treg imbalance in COPD via Wnt\/\u03b2-catenin pathway. Respir Physiol Neurobiol  2019,270,103282","journal-title":"Respir Physiol Neurobiol"},{"key":"ref=23","author":"Bujalska I.","year":"2012","unstructured":"Bujalska I.; Rabbitt E.; Stewart P.;  Effect of secreted frizzled-related protein 2 (sFRP2) from adipose tissue on pancreatic cell function Endocrine Abstracts  2012","journal-title":"Effect of secreted frizzled-related protein 2 (sFRP2) from adipose tissue on pancreatic cell function Endocrine Abstracts"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13098-019-0468-0","volume":"11","author":"Cercato C.","year":"2019","unstructured":"Cercato C.; Fonseca F.A.; Cardiovascular risk and obesity. Diabetol Metab Syndr  2019,11(1),74","journal-title":"Diabetol Metab Syndr"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"E503","DOI":"10.1210\/jc.2012-3416","volume":"98","author":"Ehrlund A.","year":"2013","unstructured":"Ehrlund A.; Mejhert N.; Lorente-Cebri\u00e1n S.; Astr\u00f6m G.; Dahlman I.; Laurencikiene J.; Ryd\u00e9n M.; Characterization of the Wnt inhibitors secreted frizzled-related proteins (SFRPs) in human adipose tissue. J Clin Endocrinol Metab  2013,98(3),E503-E508","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"C531","DOI":"10.1152\/ajpcell.00238.2013","volume":"306","author":"Mastri M.","year":"2014","unstructured":"Mastri M.; Shah Z.; Hsieh K.; Wang X.; Wooldridge B.; Martin S.; Suzuki G.; Lee T.; Secreted Frizzled-related protein 2 as a target in antifibrotic therapeutic intervention. Am J Physiol Cell Physiol  2014,306(6),C531-C539","journal-title":"Am J Physiol Cell Physiol"}],"container-title":["Current Protein &amp; Peptide Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892037339007250120100322","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/239439\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892037339007250120100322","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T07:54:42Z","timestamp":1755503682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/239439\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892037339007250120100322","relation":{},"ISSN":["1389-2037"],"issn-type":[{"value":"1389-2037","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-06-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}